{"SPADE_UN_20160": {"Sequence Information": {"Peptide Name": "BMAP-28(1-18)", "Sequence": "GGLRSLGRKILRAWKKYG", "Sequence Length": 18, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "2NDC", "UniProt Entry": [{"uniprotId": "P54229", "uniprotUrl": "http://www.uniprot.org/uniprot/P54229", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Structural insight into the mechanism of action of antimicrobial peptide BMAP-28(1-18) and its analogue mutBMAP18.", "Pubmed ID": "30336202", "Reference": "J Struct Biol. 2018;:", "Author": "Agadi N, Vasudevan S, Kumar A", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/30336202"}, {"Title": "Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells", "Pubmed ID": "", "Reference": "Int J Pept Res Ther. 2014;20:501–509", "Author": "Arpornsuwan T, Sriwai W, Jaresitthikunchai J, Phaonakrop N, Sritanaudomchai H, Roytrakul S", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/"}, {"Title": "Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus.", "Pubmed ID": "34780520", "Reference": "PLoS One. 2021;16:e0260003", "Author": "Sudadech P, Roytrakul S, Kaewprasert O, Sirichoat A, Chetchotisakd P, Kanthawong S, Faksri K", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/34780520"}], "Mass": 2059.46, "PI": 11.74, "Net Charge": 6, "Hydrophobicity": -0.67, "Frequent Amino Acids": "GKL", "Absent Amino Acids": "CDEFHMNOPQTUV", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 5, "Polar Residues": 13, "Positive Residues": 6, "Negative Residues": 0, "SPADE ID": "SPADE_UN_20160", "Similar Sequences": [{"SPADE_ID": "SPADE_N_02464", "Similarity": 1.0, "Sequence": "GGLRSLGRKILRAWKKYGPIIVPIIRIG"}, {"SPADE_ID": "SPADE_N_02486", "Similarity": 1.0, "Sequence": "GGLRSLGRKILRAWKKYGPQATPATRQ"}, {"SPADE_ID": "SPADE_N_04275", "Similarity": 1.0, "Sequence": "GGLRSLGRKILRAWKKYGPIIVPIIRI"}], "Hemolytic Activity": "Human erythrocytes:0.5% Hemolysis=50 µM,Human erythrocytes:1.9% Hemolysis=100 µM,Human erythrocytes:4.1% Hemolysis=150 µM,Human erythrocytes:0% Hemolysis=24.28 µM", "Target Organism": "Escherichia coli K-12(MIC=2µM),Escherichia coli K-12(MBC=4µM),Bacillus subtilis 168(MIC=8µM),Bacillus subtilis 168(MBC=8µM),Bacillus subtilis ATCC 6633(MIC50=8.74µM),Staphylococcus aureus ATCC 6538(MIC50=>48.56µM),Staphylococcus aureus DMST 20651(MIC50=>48.56µM),Staphylococcus epidermidis ATCC 12228(MIC50=24.28µM),Acinetobacter baumannii ATCC 19606(MIC50=7.28µM),Escherichia coli ATCC 25922(MIC50=16.99µM),Salmonella enterica subsp. enterica serovar Typhi DMST 562(MIC50=6.07µM),Human colon adenocarcinoma SW620(IC50=>48.56µM),Human squamous cell oral carcinoma HSC-4(IC50=>48.56µM),Mycobacterium abscessus ATCC 19977(MIC=>400µg/ml)"}}}